A series of novel 1, 2, 3, 5-tetrahydroimidazo [2, 1-b] quinazolin-2-one derivatives substituted with a secondary amino group has been prepared and tested for the activities of inhibiting platelet aggregation in rats in vitro and ex vivo. Most of the compounds were ...